BNTC – benitec biopharma inc. (US:NASDAQ)
Stock Stats
News
Hedge funds investors own a significant stake of 38% in Benitec Biopharma Inc. (NASDAQ:BNTC) [Yahoo! Finance]
Benitec Biopharma Inc. (NASDAQ: BNTC) was upgraded by analysts at Baird R W to a "strong-buy" rating.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $28.00 price target on the stock.
Benitec Biopharma Inc. (NASDAQ: BNTC) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $30.00 price target on the stock.
Form 4 Benitec Biopharma Inc. For: Dec 23 Filed by: Averill Madison Master Fund, Ltd.
Form 8-K Benitec Biopharma Inc. For: Dec 09
Form 4 Benitec Biopharma Inc. For: Dec 09 Filed by: Mehta Kishan
Form 4 Benitec Biopharma Inc. For: Dec 09 Filed by: Francis Peter
Form 4 Benitec Biopharma Inc. For: Dec 09 Filed by: BUCHI J KEVIN
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.